Remove Bioinformatics Remove Licensing Remove Pharmacy
article thumbnail

From siloed data to breakthroughs: multimodal AI in drug discovery

Drug Target Review

His leadership has driven international commercial success in areas including image analysis, data management, bioinformatics, advanced clinical trial data analysis leveraging machine learning and federated learning. Connect on LinkedIn >> Literature Geukes Foppen RJ, Gioia V, Zoccoli A, Velez CN.

Drugs 64
article thumbnail

United Therapeutics Corporation Reports Third Quarter 2020 Financial Results

The Pharma Data

License-related fees (5). License-related fees (5). The BREEZE study (NCT03950739) seeks to evaluate 45 patients on a stable dose of Tyvaso after switching to our new dry powder inhaler (DPI) form of treprostinil, which we licensed from MannKind Corporation. .

FDA 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Early evidence and emerging trends: How AI is shaping drug discovery and clinical development

Drug Target Review

His leadership has driven international commercial success in areas including image analysis, data management, bioinformatics, advanced clinical trial data analysis leveraging machine learning and federated learning. Connect on LinkedIn >> Literature Geukes Foppen RJ, Gioia V, Zoccoli A, Velez CN.

article thumbnail

Navigating the AI revolution: a roadmap for pharma’s future

Drug Target Review

His leadership has driven international commercial success in areas including image analysis, data management, bioinformatics, advanced clinical trial data analysis leveraging machine learning and federated learning. Connect on LinkedIn >> Literature Explainambiguity: When What You Think Is Not What You Get [Internet].

article thumbnail

Using clinical genomics and AI in drug development to elevate success

Drug Target Review

Managing this data deluge requires the expertise of multidisciplinary fields like clinical bioinformatics , which bridges statistics, biology and computer science. He also develops and presents customised training programmes (both live and virtual) for companies seeking to improve their in- and out-licensing processes.